CERS

(redirected from Cerus Corporation)
AcronymDefinition
CERSCerus Corporation (stock symbol)
CERSCenter for Excellence in Rural Safety (University of Minnesota)
CERSConsumer Education and Research Society (Ahmedabad, India)
CERSCentre for Relationship Marketing and Service Management (Hanken School of Economics; Helsinki, Finland)
CERSCertified Expert Recovery Specialist (Lunarline School of Cybersecurity; various locations)
CERSCertified Employee Retention Specialist
CERSCommittee to Elect a Republican Senate (Wisconsin)
CERSCrew Emergency Rescue System
CERSCrew Equipment Retrieval System
CERSCollection/Exam Referral System
CERSCommander Emergency Recovery Section
CERSCarrier Evaluation & Reporting System
CERSClass Event and Resource Scheduler (STASS)
CERSCombat Environment Realism System
References in periodicals archive ?
Cerus Corporation (Nasdaq:CERS) announced on Thursday that on 1 October 2016, the compensation committee of the company's board of directors granted options to purchase an aggregate of 106,300 shares of the company's common stock with a per share exercise price of USD6.
Biomedical products company Cerus Corporation (NasdaqGM:CERS) reported on Monday the appointment of Daniel Swisher as chair of its board of directors.
Isaacs, president and chief executive officer of Cerus Corporation.
Recent Cerus Corporation highlights include the following:
Cerus Corporation (Nasdaq:CERS) and Baxter Healthcare Corporation have submitted a CE Mark application for approval to market the Intercept Platelet System in Europe.
Cerus Corporation (Nasdaq:CERS) announced on Wednesday the grant of stock options and restricted stock units to Vivek K.
Cerus Corporation is building on its leading position in the biopharmaceutical industry by developing medical systems and therapeutics to provide safer and more effective options to patients.
Cerus Corporation is developing systems to enhance the safety of the world's blood supply.
Cerus Corporation is developing the Intercept Blood Systems to prevent the transmission of infectious diseases, such as HIV and hepatitis B and C, through blood transfusions, while leaving intact the therapeutic properties of the blood products.